Statement of Changes in Beneficial Ownership (4)
July 06 2021 - 5:47PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Neville Everett |
2. Issuer Name and Ticker or Trading Symbol
Cigna Corp
[
CI
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) EVP, Strategy and Business Dev |
(Last)
(First)
(Middle)
900 COTTAGE GROVE ROAD |
3. Date of Earliest Transaction
(MM/DD/YYYY)
7/1/2021 |
(Street)
BLOOMFIELD, CT 06002
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security (Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code (Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) |
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Phantom Stock Units | $0.0000 (1) | 7/1/2021 (2) | | I | | 10568.6172 | | (3) | (3) | Common Stock, $.01 Par Value | 10568.6172 | $238.3000 | 10990.8431 (4) | D | |
Explanation of Responses: |
(1) | Represents phantom stock units under the Cigna stock fund of the Express Scripts, Inc. Executive Deferred Compensation Plan. Each phantom stock unit represents the right to receive the cash value of one share of Cigna stock. |
(2) | Reporting person provided the instruction to invest in the Cigna stock fund on June 3, 2021. |
(3) | Phantom stock units are payable in cash in accordance with the terms of the Express Scripts, Inc. Executive Deferred Compensation Plan. The reporting person may transfer his interests in the Cigna stock fund into an alternative investment account. |
(4) | Includes 3.5394 phantom stock units acquired pursuant to a dividend reinvestment feature of the Express Scripts, Inc. Executive Deferred Compensation Plan. |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
Neville Everett 900 COTTAGE GROVE ROAD BLOOMFIELD, CT 06002 |
|
| EVP, Strategy and Business Dev |
|
Signatures
|
By: Jill M. Stadelman, attorney-in-fact | | 7/6/2021 |
**Signature of Reporting Person | Date |
Cigna (NYSE:CI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Cigna (NYSE:CI)
Historical Stock Chart
From Apr 2023 to Apr 2024